These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36012557)

  • 1. Deletion of Macrophage-Specific Glycogen Synthase Kinase (GSK)-3α Promotes Atherosclerotic Regression in
    Patel S; Mastrogiacomo L; Fulmer M; Shi Y; Werstuck GH
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycogen synthase kinase 3α deficiency attenuates atherosclerosis and hepatic steatosis in high fat diet-fed low density lipoprotein receptor-deficient mice.
    Banko NS; McAlpine CS; Venegas-Pino DE; Raja P; Shi Y; Khan MI; Werstuck GH
    Am J Pathol; 2014 Dec; 184(12):3394-404. PubMed ID: 25451156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterizing the Role of Glycogen Synthase Kinase-3α/β in Macrophage Polarization and the Regulation of Pro-Atherogenic Pathways in Cultured Ldlr
    Patel S; Werstuck G
    Front Immunol; 2021; 12():676752. PubMed ID: 34394077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of Myeloid GSK3α Attenuates Atherosclerosis and Promotes an M2 Macrophage Phenotype.
    McAlpine CS; Huang A; Emdin A; Banko NS; Beriault DR; Shi Y; Werstuck GH
    Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1113-22. PubMed ID: 25767272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-phenylbutyrate and valproate treatment attenuates the progression of atherosclerosis and stabilizes existing plaques.
    Huang A; Young TL; Dang VT; Shi Y; McAlpine CS; Werstuck GH
    Atherosclerosis; 2017 Nov; 266():103-112. PubMed ID: 29024862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating the Role of Endothelial Glycogen Synthase Kinase3α/β in Atherogenesis in Low Density Lipoprotein Receptor Knockout Mice.
    Mastrogiacomo L; Werstuck GH
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase R-like endoplasmic reticulum kinase and glycogen synthase kinase-3α/β regulate foam cell formation.
    McAlpine CS; Werstuck GH
    J Lipid Res; 2014 Nov; 55(11):2320-33. PubMed ID: 25183803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear factor E2-related factor 2 deficiency impairs atherosclerotic lesion development but promotes features of plaque instability in hypercholesterolaemic mice.
    Ruotsalainen AK; Lappalainen JP; Heiskanen E; Merentie M; Sihvola V; Näpänkangas J; Lottonen-Raikaslehto L; Kansanen E; Adinolfi S; Kaarniranta K; Ylä-Herttuala S; Jauhiainen M; Pirinen E; Levonen AL
    Cardiovasc Res; 2019 Jan; 115(1):243-254. PubMed ID: 29917052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of age, diet, and type 2 diabetes on the development and FDG uptake of atherosclerotic plaques.
    Silvola JM; Saraste A; Laitinen I; Savisto N; Laine VJ; Heinonen SE; Ylä-Herttuala S; Saukko P; Nuutila P; Roivainen A; Knuuti J
    JACC Cardiovasc Imaging; 2011 Dec; 4(12):1294-301. PubMed ID: 22172786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid β-Catenin Deficiency Exacerbates Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice.
    Wang F; Liu Z; Park SH; Gwag T; Lu W; Ma M; Sui Y; Zhou C
    Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1468-1478. PubMed ID: 29724817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of High Fat Feeding and Diabetes on Regression of Atherosclerosis Induced by Low-Density Lipoprotein Receptor Gene Therapy in LDL Receptor-Deficient Mice.
    Willecke F; Yuan C; Oka K; Chan L; Hu Y; Barnhart S; Bornfeldt KE; Goldberg IJ; Fisher EA
    PLoS One; 2015; 10(6):e0128996. PubMed ID: 26046657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SIRT2 decreases atherosclerotic plaque formation in low-density lipoprotein receptor-deficient mice by modulating macrophage polarization.
    Zhang B; Ma Y; Xiang C
    Biomed Pharmacother; 2018 Jan; 97():1238-1242. PubMed ID: 29145149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficiency of HIF1α in Antigen-Presenting Cells Aggravates Atherosclerosis and Type 1 T-Helper Cell Responses in Mice.
    Chaudhari SM; Sluimer JC; Koch M; Theelen TL; Manthey HD; Busch M; Caballero-Franco C; Vogel F; Cochain C; Pelisek J; Daemen MJ; Lutz MB; Görlach A; Kissler S; Hermanns HM; Zernecke A
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2316-25. PubMed ID: 26404487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CalDAG-GEFI Deficiency Reduces Atherosclerotic Lesion Development in Mice.
    Boulaftali Y; Owens AP; Beale A; Piatt R; Casari C; Lee RH; Conley PB; Paul DS; Mackman N; Bergmeier W
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):792-9. PubMed ID: 26988592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High fat / high cholesterol diet does not provoke atherosclerosis in the ω3-and ω6-polyunsaturated fatty acid synthesis-inactivated Δ6-fatty acid desaturase-deficient mouse.
    Stoffel W; Binczek E; Schmidt-Soltau I; Brodesser S; Wegner I
    Mol Metab; 2021 Dec; 54():101335. PubMed ID: 34530175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced calcification and osteogenic features in advanced atherosclerotic plaques of mice with macrophage-specific loss of TRPC3.
    Dube PR; Chikkamenahalli LL; Birnbaumer L; Vazquez G
    Atherosclerosis; 2018 Mar; 270():199-204. PubMed ID: 29290366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloid Cell PKM2 Deletion Enhances Efferocytosis and Reduces Atherosclerosis.
    Doddapattar P; Dev R; Ghatge M; Patel RB; Jain M; Dhanesha N; Lentz SR; Chauhan AK
    Circ Res; 2022 Apr; 130(9):1289-1305. PubMed ID: 35400205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipocyte enhancer-binding protein 1 (AEBP1) (a novel macrophage proinflammatory mediator) overexpression promotes and ablation attenuates atherosclerosis in ApoE (-/-) and LDLR (-/-) mice.
    Bogachev O; Majdalawieh A; Pan X; Zhang L; Ro HS
    Mol Med; 2011; 17(9-10):1056-64. PubMed ID: 21687917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA 302a is a novel modulator of cholesterol homeostasis and atherosclerosis.
    Meiler S; Baumer Y; Toulmin E; Seng K; Boisvert WA
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):323-31. PubMed ID: 25524771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nrf2 in bone marrow-derived cells positively contributes to the advanced stage of atherosclerotic plaque formation.
    Harada N; Ito K; Hosoya T; Mimura J; Maruyama A; Noguchi N; Yagami K; Morito N; Takahashi S; Maher JM; Yamamoto M; Itoh K
    Free Radic Biol Med; 2012 Dec; 53(12):2256-62. PubMed ID: 23051009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.